Latest "Seattle Biomedical Research Institute" News Stories

22:24 EDT 22nd July 2018 | BioPortfolio

Here are the most relevant search results for "Seattle Biomedical Research Institute" found in our extensive news archives from over 250 global news sources.

More Information about Seattle Biomedical Research Institute on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Seattle Biomedical Research Institute for you to read. Along with our medical data and news we also list Seattle Biomedical Research Institute Clinical Trials, which are updated daily. BioPortfolio also has a large database of Seattle Biomedical Research Institute Companies for you to search.

Showing "Seattle Biomedical Research Institute" News Articles 1–25 of 29,000+


Texas researchers take on mysterious children's illness

(Texas Biomedical Research Institute) Texas Biomedical Research Institute and The Children's Hospital of San Antonio have joined forces to cure a mysterious condition called Kawasaki disease. The illness which affects young children is named after the Japanese doctor who first described it more than 50 years ago.

Promising treatment for Ebola to be tested at Texas Biomed

(Texas Biomedical Research Institute) During the West African Ebola outbreak that began in 2013, an experimental biopharmaceutical drug called ZMappTM was a glimmer of hope in the midst of a health crisis. Now, scientists at Texas Biomedical Research Institute in San Antonio have been awarded a $2 million dollar contract by the makers of ZMapp, Mapp Biopharmaceutical, Inc., to further test this pr...

Centerline Biomedical

Centerline Biomedical, Inc. was founded in 2014 as a spinoff of the Cleveland Clinic to commercialize their innovative vascular navigation technology. With a research, development, and design history rooted in the Clinic’s world-class Lerner Research Institute’s Heart and Vascular Institute, the IOPS™ platform can be further used for predictive modeling, clinical decision support, global hea...

LSU Pennington Biomedical Research Center approved for $4.5M childhood obesity treatment study

(Louisiana State University) A research team at LSU's Pennington Biomedical Research Center has been approved for a five-year, $4.5 million funding award by the Patient-Centered Outcomes Research Institute, or PCORI, to evaluate two treatments for children who have obesity.

Repurposing promising cancer drugs may lead to a new approach to treating TB

(Texas Biomedical Research Institute) Promising experimental cancer chemotherapy drugs may help knock out another life-threatening disease: tuberculosis (TB). A new study published by scientists at Texas Biomedical Research Institute in San Antonio pinpoints a mechanism in regulating cell death called apoptosis that is a potential new target for helping to control the bacterial infection (Mycobact...

Can GSK and Altius reshape the way drug development is conducted?

Lon Cardon, GSK, and John Stamatoyannopoulos, University of Washington, discuss the recent launch of Altius Institute for Biomedical Sciences. Funded by GSK, Altius is an independent non-profit research institute focused on genomic research.

Pennington Biomedical awarded $4.5 million funding to evaluate treatments for childhood obesity

A research team at LSU's Pennington Biomedical Research Center has been approved for a five-year, $4.5 million funding award by the Patient-Centered Outcomes Research Institute, or PCORI, to evaluate two treatments for children who have obesity.

Surprising Discovery Could Improve Malaria Detection Worldwide

New research underway at Seattle Children’s Research Institute could pave the way for a rapid screening test capable of diagnosing submicroscopic infections

Scientist behind Dolly the cloned sheep, a key to Parkinson’s research, has disease himself – Seattle Times

Seattle TimesScientist behind Dolly the cloned sheep, a key to Parkinson's research, has disease himselfSeattle TimesSeven-month-old Dolly, the genetically cloned sheep, looks towards the camera at the Roslin Institute Tuesday, Feb. 25, 1997. It was revealed Tuesday that Dolly, the first animal to be genetically cloned from adult cells, got her name from Country ...Parkinson's Pioneer Dr. Ian Wilm...

Non-car commuting options winning over downtown Seattle workers in droves

So, what’s it like for a city’s downtown workers to forego the car and utilize other means in terms of satisfying or fulfilling duties? Just ask Seattle, Washington, the Pacific Northwest-located city. Commute Seattle in a 2014 “Downtown Seattle Commuter Trends” press release reported, “[m]ore people are commuting to Downtown Seattle than ever, but the […]

TGen tests ultrasound as way to enhance cancer drug delivery

(The Translational Genomics Research Institute) A Norwegian biotech company called Phoenix Solutions AS is working with the Translational Genomics Research Institute (TGen), a Phoenix, Arizona-based biomedical research facility, to test the use of these pulsed sound waves to direct and focus cancer drug therapies.

Time to end the federal ban on gun violence research funding

In recent weeks, the firearms controversy has again lit up the media in the United States, with clarification that anyone engaged in the business of selling firearms must get a license and conduct background checks. But, argues Fred Rivara from the Seattle Children’s Research Institute and Harborview Injury Prevention and Research Center, we may...

What’s Hot in Seattle Biotech: Tech, Life Sciences Convergence & More

Like a good cup of coffee, Seattle’s life sciences ecosystem is a balanced blend of complementary parts: research to find the underpinnings of disease, and information technology that helps scientists make sense of the data. That convergence was on display last week at Xconomy’s annual What’s Hot in Seattle Biotech event. Here are a few […]

NIH experts call for transformative research approach to end tuberculosis

(NIH/National Institute of Allergy and Infectious Diseases) A more intensive biomedical research approach is necessary to control and ultimately eliminate tuberculosis (TB), according to a perspective published in The American Journal of Tropical Medicine and Hygiene. In the article, authors Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, and Robert W...

Carol Monaghan, MP, Parliamentary Questions on ME/CFS and Biomedical Research Funding | 23 May 2018

The Minister of State for Health and Social Care responds to biomedical research question.

Seattle Genetics Acquires Cascadian Therapeutics, Continuing a Strong ...

On January 31, two Seattle biotech companies, Seattle Genetics and Cascadian Therapeutics, announced a merger agreement under which Seattle Genetics will acquire Cascadian Therapeutics for $614 million. [1] The announcement catapulted Cascadian Therapeutics shares to a 16-month high, and a 69% increase over the previous day's closing price.

Get the Inside Scoop on Seattle Life Sciences at Xconomy’s June Event

Xconomy’s annual Seattle-area life sciences conference will be held on June 12 at Cambia Grove in the Emerald City’s downtown. “What’s Hot in Seattle Biotech” will look at what’s hot, and what’s next, for the Puget Sound region’s life sciences scene. It’s only March , but already this year, Seattle’s life science community has seen […]

Seattle Genetics to Acquire Cascadian Therapeutics for $614 Million, Adding Late-Stage Breast Cancer Program

att BOTHELL, Wash. & SEATTLE–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) and Cascadian Therapeutics, Inc. (Nasdaq:CASC) today announced the signing of a definitive merger agreement under which Seattle Genetics has agreed to acquire Cascadian Therapeutics. Under the terms of the agreement, Seattle Genetics will pay $10.00 per share in cash, or approximately $614 million. T...

"MARY JANES: THE WOMEN OF WEED," A Groundbreaking Documentary About Women as They Lead the Cannabis Industry, Debuts in Seattle

SEATTLE - April 19, 2018 ( Newswire) Eden Labs, Inc. will host an exclusive Seattle premiere screening of the feature-length film, Mary Janes: The Women of Weed in The Seattle Art Museum Plestcheeff Auditorium at 6:30 PM on May 15, 2018.

Sanya city raise concerns in Seattle as its sailing promotion

On the24 thofApril, John Boesche, vice president of Visit Seattle International Tourism and Marcus Carney, tourism manager of Visit Seattle, Read more...

Seattle Museum Month Means Big Savings for Visitors in February

A wide array of institutions, attractions, and exhibits are part of this offer including the Seattle Art Museum, Tacoma Art Museum, Seattle Children's Museum, Museum Read more...

PolarityTE Acquires Operating GLP/USDA Preclinical Biomedical Research Facility

PolarityTE, (NASDAQ:COOL) announced the acquisition of a preclinical biomedical research facility in order to accelerate research and development of PolarityTE pipeline products. The facility is an already fully-functional, operational and profitable contract research organization (CRO) which is regulated and compliant under both Good Laboratory Practices (GLP) and United States Department of Agri...

Personalized Lifestyle Medicine Institute Brings an Innovative Approach to Medical Conferences

SEATTLE, April 24, 2018/PRNewswire/ -- The Personalized Lifestyle Medicine Institute (PLMI) will host the Sixth Annual Thought Leaders Consortium Oct. 12-13, 2018at the Read more...

PharmaMar lizensiert vollsynthetisch aus Meeressubstanzen gewonnene Payloads für Wirkstoff-Konjugate an Seattle Genetics

Madrid (ots/PRNewswire) - PharmaMar (MCE: PHM) hat heute die Unterzeichnung einer exklusiven Lizenzvereinbarung mit Seattle Genetics Inc. (SGEN: NASDAQ GS) bekanntgegeben, nach der Seattle Genetics...

Seattle Genetics acquires Cascadian Therapeutics

Seattle Genetics Inc. agreed to pay $614mm ($10 per share in cash, a 107% premium) to acquire fellow Seattle-based cancer bio...

Quick Search


News Quicklinks